Gray-matter volume in methamphetamine dependence: Cigarette smoking and changes with abstinence from methamphetamine

Drug and Alcohol Dependence

Volumn 125, Issue 3, 2012, Pages 230-238

  Morales, Angelica M ^a   Lee, Buyean ^a   Hellemann, Gerhard ^a   O'Neill, Joseph ^a   London, Edythe D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caudate nucleus; Cigarette smoking; Longitudinal; Methamphetamine; Prefrontal cortex; Voxel based morphometry

Indexed keywords

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANALYSIS OF COVARIANCE; ANGULAR GYRUS; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CIGARETTE SMOKING; CONTROLLED STUDY; CORPUS STRIATUM; CROSS-SECTIONAL STUDY; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; INFERIOR FRONTAL GYRUS; INSULA; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; NEUROIMAGING; ORBITAL CORTEX; PHYSICAL EXAMINATION; PRECUNEUS; PRIORITY JOURNAL; SEX DIFFERENCE; SUPERIOR TEMPORAL GYRUS; VOXEL BASED MORPHOMETRY;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; FEMALE; GLOBUS PALLIDUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; MIDDLE AGED; NEOSTRIATUM; PREFRONTAL CORTEX; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84866366199     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.02.017     Document Type: Article

References (52)

1. Almeida O.P., Garrido G.J., Lautenschlager N.T., Hulse G.K., Jamrozik K., Flicker L. Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease. Am. J. Geriatr. Psychiatry 2008, 16:92-98.
2. Asanuma M., Miyazaki I., Higashi Y., Tsuji T., Ogawa N. Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity. Ann. N. Y. Acad. Sci. 2004, 1025:69-75.
3. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
4. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
5. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
6. Berman S., O'Neill J., Fears S., Bartzokis G., London E.D. Abuse of amphetamines and structural abnormalities in the brain. Ann. N. Y. Acad. Sci. 2008, 1141:195-220.
7. Berman S.M., Voytek B., Mandelkern M.A., Hassid B.D., Isaacson A., Monterosso J., Miotto K., Ling W., London E.D. Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol. Psychiatry 2008, 13:897-908.
8. Brecht M.L., von Mayrhauser C., Anglin M.D. Predictors of relapse after treatment for methamphetamine use. J. Psychoactive Drugs 2000, 32:211-220.
9. Brody A.L., Mandelkern M.A., Jarvik M.E., Lee G.S., Smith E.C., Huang J.C., Bota R.G., Bartzokis G., London E.D. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol. Psychiatry 2004, 55:77-84.
10. Buhler M., Mann K. Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol. Clin. Exp. Res. 2011, 35:1771-1793.
11. Cadet J.L., Krasnova I.N. Molecular bases of methamphetamine-induced neurodegeneration. Int. Rev. Neurobiol. 2009, 88:101-119.
12. Chang L., Cloak C., Patterson K., Grob C., Miller E.N., Ernst T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol. Psychiatry 2005, 57:967-974.
13. Chang L., Alicata D., Ernst T., Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007, 102(Suppl. 1):16-32.
14. Coupe P., Yger P., Barillot C. Fast non local means denoising for 3D MR images. Med. Image Comput. Comput. Assist. Interv. 2006, 9:33-40.
15. Cuadra M.B., Cammoun L., Butz T., Cuisenaire O., Thiran J.P. Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans. Med. Imaging 2005, 24:1548-1565.
16. Das, D., Cherbuin, N., Anstey, K.J., Sachdev, P.S., Easteal, S. Lifetime cigarette smoking is associated with striatal volume measures. Addict. Biol., [epub ahead of print], in press.
17. Dean A.C., Hellemann G., Sugar C.A., London E.D. Educational attainment is not a good proxy for cognitive function in methamphetamine dependence. Drug Alcohol Depend. 2011, (Epub ahead of print, 12/2011).
18. Durazzo T.C., Cardenas V.A., Studholme C., Weiner M.W., Meyerhoff D.J. Non-treatment-seeking heavy drinkers: effects of chronic cigarette smoking on brain structure. Drug Alcohol Depend. 2007, 87:76-82.
19. Ernst T., Chang L., Leonido-Yee M., Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000, 54:1344-1349.
20. Fagerstrom K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 1978, 3:235-241.
21. Ferrea S., Winterer G. Neuroprotective and neurotoxic effects of nicotine. Pharmacopsychiatry 2009, 42:255-265.
22. First M.B., Spitzer R.L., Gibbon M., Williams J.B. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-IP) 1995, American Psychiatric Press, Washington, DC.
23. Franklin T.R., Acton P.D., Maldjian J.A., Gray J.D., Croft J.R., Dackis C.A., O'Brien C.P., Childress A.R. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol. Psychiatry 2002, 51:134-142.
24. Gallinat J., Meisenzahl E., Jacobsen L.K., Kalus P., Bierbrauer J., Kienast T., Witthaus H., Leopold K., Seifert F., Schubert F., Staedtgen M. Smoking and structural brain deficits: a volumetric MR investigation. Eur. J. Neurosci. 2006, 24:1744-1750.
25. Hayasaka S., Phan K.L., Liberzon I., Worsley K.J., Nichols T.E. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 2004, 22:676-687.
26. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-Notestine C., Mindt M.R., Marcotte T.D., Heaton R.K., Ellis R.J., Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am. J. Psychiatry 2005, 162:1461-1472.
27. Kim S.J., Lyoo I.K., Hwang J., Chung A., Hoon Sung Y., Kim J., Kwon D.H., Chang K.H., Renshaw P.F. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int. J. Neuropsychopharmacol. 2006, 9:221-228.
28. Koutsouleris N., Patschurek-Kliche K., Scheuerecker J., Decker P., Bottlender R., Schmitt G., Rujescu D., Giegling I., Gaser C., Reiser M., Moller H.J., Meisenzahl E.M. Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis. Schizophr. Res. 2010, 123:160-174.
29. Kuhn S., Schubert F., Gallinat J. Reduced thickness of medial orbitofrontal cortex in smokers. Biol. Psychiatry 2010, 68:1061-1065.
30. Lorenzetti V., Lubman D.I., Whittle S., Solowij N., Yucel M. Structural MRI findings in long-term cannabis users: what do we know?. Subst. Use Misuse 2010, 45:1787-1808.
31. Mactutus C.F. Developmental neurotoxicity of nicotine, carbon monoxide, and other tobacco smoke constituents. Ann. N. Y. Acad. Sci. 1989, 562:105-122.
32. Manjon J.V., Tohka J., Garcia-Marti G., Carbonell-Caballero J., Lull J.J., Marti-Bonmati L., Robles M. Robust MRI brain tissue parameter estimation by multistage outlier rejection. Magn. Reson. Med. 2008, 59:866-873.
33. Matochik J.A., Eldreth D.A., Cadet J.L., Bolla K.I. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend. 2005, 77:23-30.
34. McLellan A.T., Cacciola J.C., Alterman A.I., Rikoon S.H., Carise D. The Addiction Severity Index at 25: origins, contributions and transitions. Am. J. Addict. 2006, 15:113-124.
35. Nakama H., Chang L., Cloak C., Jiang C., Alicata D., Haning W. Association between psychiatric symptoms and craving in methamphetamine users. Am. J. Addict. 2008, 17:441-446.
36. Nakama H., Chang L., Fein G., Shimotsu R., Jiang C.S., Ernst T. Methamphetamine users show greater than normal age-related cortical gray matter loss. Addiction 2011, (Epub ahead of print, 5/2011).
37. Rajapakse J.C., Giedd J.N., Rapoport J.L. Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans. Med. Imaging 1997, 16:176-186.
38. Ridgway G.R., Omar R., Ourselin S., Hill D.L., Warren J.D., Fox N.C. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 2009, 44:99-111.
39. Ryan R.E., Ross S.A., Drago J., Loiacono R.E. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br. J. Pharmacol. 2001, 132:1650-1656.
40. Schwartz D.L., Mitchell A.D., Lahna D.L., Luber H.S., Huckans M.S., Mitchell S.H., Hoffman W.F. Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage 2010, 50:1392-1401.
41. Sekine Y., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., Iwata Y., Tsuchiya K.J., Suda S., Suzuki K., Kawai M., Takebayashi K., Yamamoto S., Matsuzaki H., Ueki T., Mori N., Gold M.S., Cadet J.L. Methamphetamine causes microglial activation in the brains of human abusers. J. Neurosci. 2008, 28:5756-5761.
42. Simon S.L., Dean A.C., Cordova X., Monterosso J.R., London E.D. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J. Stud. Alcohol Drugs 2010, 71:335-344.
43. Steinkellner T., Freissmuth M., Sitte H.H., Montgomery T. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine. Biol. Chem. 2011, 392:103-115.
44. Tabibnia G., Monterosso J.R., Baicy K., Aron A.R., Poldrack R.A., Chakrapani S., Lee B., London E.D. Different forms of self-control share a neurocognitive substrate. J. Neurosci. 2011, 31:4805-4810.
45. Thomas D.M., Walker P.D., Benjamins J.A., Geddes T.J., Kuhn D.M. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J. Pharmacol. Exp. Ther. 2004, 311:1-7.
46. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., London E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 2004, 24:6028-6036.
47. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 2001, 21:9414-9418.
48. Wang G.J., Volkow N.D., Chang L., Miller E., Sedler M., Hitzemann R., Zhu W., Logan J., Ma Y., Fowler J.S. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am. J. Psychiatry 2004, 161:242-248.
49. Weinberger A.H., Sofuoglu M. The impact of cigarette smoking on stimulant addiction. Am. J. Drug Alcohol Abuse 2009, 35:12-17.
50. Yamamoto B.K., Bankson M.G. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 2005, 17:87-117.
51. Zhang X., Salmeron B.J., Ross T.J., Geng X., Yang Y., Stein E.A. Factors underlying prefrontal and insula structural alterations in smokers. Neuroimage 2011, 54:42-48.
52. Zorick T., Nestor L., Miotto K., Sugar C., Hellemann G., Scanlon G., Rawson R., London E.D. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction 2010, 105:1809-1818.